Introduction and Basics of Image Interpretation
Click below to access your content. Note you must complete both the course content and the evaluation survey in order to claim your certificate. When you have completed the course content, please return to this page and click on the Claim Survey link below to access your certificate. Once you have successfully completed this course your certificate will become available at the top of this page and on your My Certificates page.
Course Details
Credit/contact hours: 0.5
Estimated time to complete: 30 minutes
Publication Date: December 6, 2018
Expiration date: December 6, 2024
Reviewed: December 5, 2021
Description:
Myocardial nuclear imaging provides valuable anatomic and prognostic information with respect to coronary heart disease. There are, however, important limitations to this imaging. To understand the proper clinical interpretation of perfusion imaging scans it is important understand the basic principles of coronary blood flow, atherosclerosis, and the principles underlying nuclear perfusion imaging.
You Will Learn
- To understand why nuclear imaging works with respect to the Glagov Phenomenon and the stenosis – coronary blood flow relationship
- To describe the ischemic cascade with respect to the relationship of coronary ischemia and clinical findings
- To explain the causes of the limited sensitivity and specificity of myocardial perfusion imaging
- To interpret typical findings of myocardial perfusion imaging
Method and medium:
Jamieson M. Bourque, MD
Dr. Jamieson Bourque currently serves as the Medical Director of Nuclear Cardiology. He attended UVA as an undergraduate and then completed medical school and residency at Duke. Dr. Bourque returned for a cardiology fellowship and joined the faculty. His research interests include coronary microvascular disease and methods of risk stratification in patients undergoing evaluation for ischemic heart disease.
DISCLOSURE: Jamieson M. Bourque has disclosed relevant financial relationship as consultant to Pfizer and industry funded research/investigator of Astellas Pharma.
